BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (Paris:IMPL), a medical technology company specializing in vertebral and knee-surgery implants, today announces its annual results for the financial year ending December 31, 2015, as approved by the Board on March 24, 2016. Ludovic Lastennet, CEO of Implanet, says: “We are continuing the […]